Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.

MLA

Soiberman, Uri, et al. “Subconjunctival Injectable Dendrimer-Dexamethasone Gel for the Treatment of Corneal Inflammation.” Biomaterials, vol. 125, May 2017, pp. 38–53. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2017.02.016.

APA

Soiberman, U., Kambhampati, S. P., Wu, T., Mishra, M. K., Oh, Y., Sharma, R., Wang, J., Al Towerki, A. E., Yiu, S., Stark, W. J., & Kannan, R. M. (2017). Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation. Biomaterials, 125, 38–53. https://doi.org/10.1016/j.biomaterials.2017.02.016

Chicago

Soiberman, Uri, Siva P. Kambhampati, Tony Wu, Manoj K. Mishra, Yumin Oh, Rishi Sharma, Jiangxia Wang, et al. 2017. “Subconjunctival Injectable Dendrimer-Dexamethasone Gel for the Treatment of Corneal Inflammation.” Biomaterials 125 (May): 38–53. doi:10.1016/j.biomaterials.2017.02.016.